Maria Tsilika, Esther Taks, Konstantinos Dolianitis, Antigone Kotsaki, Konstantinos Leventogiannis, Christina Damoulari, Maria Kostoula, Maria Paneta, Georgios Adamis, Ilias Papanikolaou, Kimon Stamatelopoulos, Amalia Bolanou, Konstantinos Katsaros, Christina Delavinia, Ioannis Perdios, Aggeliki Pandi, Konstantinos Tsiakos, Nektarios Proios, Emmanouela Kalogianni, Ioannis Delis, Efstathios Skliros, Karolina Akinosoglou, Aggeliki Perdikouli, Garyfallia Poulakou, Haralampos Milionis, Eva Athanassopoulou, Eleftheria Kalpaki, Leda Efstratiou, Varvara Perraki, Antonios Papadopoulos, Mihai G Netea, Evangelos J. Giamarellos-Bourboulis

ACTIVATE-2 a double blind randomized trial of BCG vaccination against COVID 19 in individuals at risk

Frontiers in Immunology 2022 Jul 5;13:873067
DOI 10.3389/fimmu.2022.873067Download pdf 🡇

Funding

The study was funded in part by the Hellenic Institute for the Study of Sepsis and in part by Fast Grants of Emergent Ventures at the Mercatus Center, George Mason University.

Keywords: BCG; COVID-19; SARS-CoV-2; elderly vaccination; trained immunity
Related Studies: ACTIVATE-2